Google
FENC — FENNEC PHARMACEUTICALS INC (Healthcare >> Biotechnology)
FENC FAQ
What is FENC's P/E ratio?
FENNEC PHARMACEUTICALS INC (FENC) currently trades at a P/E ratio of 1,503.54.
What is FENC's ROE?
FENNEC PHARMACEUTICALS INC reports a Return on Equity (ROE) of -22.23%.
What is FENC's dividend yield?
FENNEC PHARMACEUTICALS INC offers a dividend yield of 0.00%.
What is FENC's Deepscope Quality Score?
Deepscope rates FENC's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy FENC?
Deepscope's AI Timing Score for FENC is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does FENC belong to?
FENNEC PHARMACEUTICALS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 8.70
Price
-0.46
(-5.02%)
Day Change
|
|
|---|
FENC, ファンダメンタルスコアはnot good ( ファンダメンタル = 46) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/Eが高い。割高銘柄。
ROEが低い
ROAが低い
ROEの伸びが低い
昨年度のROEが一昨年比で低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 78 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 8.70 |
| PBV / Sector |
8.02 / 4.63
|
| Earning Per Share | -0.24 |
| PE / Sector |
1,503.54 / 17.43
GREAT
|
| PEG or PE/Growth / Sector |
2.37 / 0.53
|
| Average 1M Daily Value |
3.78 M
GREAT
|
| Average 1W Daily Value |
2.46 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
56% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-06 09:09:24 |
| Symbol | FENC |
| Name | FENNEC PHARMACEUTICALS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 34.74 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 302.21 / 8,857.28 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 68 TW Alexander Drive, Research Triangle Park, NC, United States, 27709
Phone: 919 636 4530
Website: https://www.fennecpharma.com
Sector: Healthcare >> Biotechnology
Description: Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
